Ubs Group Ag Globus Medical Inc Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Globus Medical Inc stock. As of the latest transaction made, Ubs Group Ag holds 176,535 shares of GMED stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

176,535

Previous 169,172 4.35%

Holding current value

$12.1 Million

Previous $9.02 Million 5.04%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$51.15 - $56.52 $376,617 - $416,156	7,363 Added 4.35%	176,535 $9.47 Million
Q4 2023 Feb 09, 2024	SELL	$43.79 - $55.14 $2.16 Million - $2.72 Million	-49,398 Reduced 22.6%	169,172 $9.02 Million
Q3 2023 Nov 09, 2023	BUY	$49.1 - $62.37 $5.22 Million - $6.63 Million	106,269 Added 94.63%	218,570 $10.9 Million
Q2 2023 Aug 11, 2023	BUY	$52.61 - $59.54 $1.57 Million - $1.78 Million	29,832 Added 36.17%	112,301 $6.69 Million
Q1 2023 May 12, 2023	SELL	$51.83 - $79.63 $1.59 Million - $2.44 Million	-30,587 Reduced 27.05%	82,469 $4.67 Million

Q4 2022 Feb 08, 2023	BUY	$58.4 - $75.53 $2.49 Million - $3.21 Million	42,559 Added 60.37%	113,056 $8.4 Million
Q3 2022 Nov 10, 2022	SELL	$55.32 - $67.54 $6,306 - $7,699	-114 Reduced 0.16%	70,497 $4.2 Million
Q2 2022 Aug 10, 2022	SELL	$53.08 - $81.37 $1.15 Million - $1.76 Million	-21,582 Reduced 23.41%	70,611 $3.96 Million
Q1 2022 May 16, 2022	SELL	$63.68 - $75.54 $2.99 Million - $3.55 Million	-46,985 Reduced 33.76%	92,193 $6.8 Million
Q4 2021 Feb 14, 2022	BUY	$62.62 - $79.92 $3.46 Million - $4.42 Million	55,256 Added 65.84%	139,178 $10 Million
Q3 2021 Nov 15, 2021	SELL	$76.41 - $84.06 $415,288 - $456,866	-5,435 Reduced 6.08%	83,922 $6.43 Million
Q2 2021 Aug 13, 2021	BUY	$61.85 - $77.53 $1.22 Million - $1.53 Million	19,716 Added 28.31%	89,357 $6.93 Million
Q1 2021 May 12, 2021	SELL	$60.05 - $67.74 $195,642 - $220,696	-3,258 Reduced 4.47%	69,641 $4.3 Million
Q4 2020 Feb 11, 2021	SELL	$48.89 - $65.87 $1.24 Million - $1.67 Million	-25,381 Reduced 25.83%	72,899 $4.75 Million
Q3 2020 Nov 12, 2020	BUY	$45.26 - $57.82 $2.79 Million - $3.57 Million	61,723 Added 168.84%	98,280 $4.87 Million
Q2 2020 Jul 31, 2020	SELL	$39.81 - $55.61 $634,451 - $886,256	-15,937 Reduced 30.36%	36,557 $1.74 Million
Q1 2020 May 01, 2020	SELL	$35.06 - $59.45 $4.07 Million - $6.91 Million	-116,216 Reduced 68.89%	52,494 $2.23 Million
Q4 2019 Feb 14, 2020	BUY	$49.45 - $59.5 $2.28 Million - $2.75 Million	46,190 Added 37.7%	168,710 $9.93 Million
Q3 2019 Nov 14, 2019	BUY	$40.41 - $52.32 $1.97 Million - $2.56 Million	48,851 Added 66.31%	122,520 $6.26 Million
Q2 2019 Aug 14, 2019	SELL	$39.3 - $48.41 $2.8 Million - $3.45 Million	-71,198 Reduced 49.15%	73,669 $3.12 Million
Q1 2019 May 14, 2019	SELL	$38.08 - $49.41 $5.14 Million - $6.66 Million	-134,861 Reduced 48.21%	144,867 $7.16 Million
Q4 2018 Feb 14, 2019	BUY	$41.38 - $57.44 $1.11 Million - $1.54 Million	26,838 Added 10.61%	279,728 $12.1 Million
Q3 2018 Nov 14, 2018	BUY	$50.24 - $56.76 $7.32 Million - $8.27 Million	145,671 Added 135.86%	252,890 $14.4 Million
Q2 2018 Aug 14, 2018	BUY	$47.96 - $57.41 $3.13 Million - $3.74 Million	65,168 Added 154.97%	107,219 $5.41 Million
Q1 2018 May 15, 2018	BUY	$42.75 - $51.73 $215,032 - $260,201	5,030 Added 13.59%	42,051 $2.1 Million
Q4 2017 Feb 14, 2018	SELL	$28.86 - $41.64 $450,822 - $650,458	-15,621 Reduced 29.67%	37,021 $1.52 Million
Q3 2017 Nov 14, 2017	SELL	$28.28 - $30.85 $580,390 - $633,134	-20,523 Reduced 28.05%	52,642 $1.57 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-17,116 Reduced 18.96%	73,165 $2.43 Million
Q1 2017 Nov 14, 2017	BUY	N/A	90,281	90,281 $2.68 Million

Others Institutions Holding GMED

# of Institutions

460

Shares Held

108M

Call Options Held

213K

Put Options Held

112K

View Full List

About GLOBUS MEDICAL INC

Ticker GMED
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 77,037,200
Market Cap $5.29B
Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...

More about GMED

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account